---
schema_version: "secwatch.filing_event.v1"
accession: "0001178913-26-000875"
form_type: "8-K"
ticker: "LFWD"
cik: "0001607962"
company_name: "Lifeward Ltd."
filed_at: "2026-03-13T23:59:59+00:00"
generated_at: "2026-05-15T12:34:58.372485+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Lifeward shareholders approve Oratech Pharma acquisition and related proposals

## Summary
- Proposal 1 passed: issuance of ordinary shares to Oramed for Oratech acquisition (1,854,591 for, 470,084 against).
- Proposal 2 passed: election of two external directors contingent on closing of Oratech acquisition.
- Proposal 5 passed: equity grant to CEO Mark Grant (1,656,670 for, 674,846 against).
- Proposal 6 passed: reappointment of Ernst & Young as auditor for FY 2026 (6,175,644 for).

## SEC filing metadata
- accession: 0001178913-26-000875
- form_type: 8-K
- ticker: LFWD
- cik: 0001607962
- company_name: Lifeward Ltd.
- filed_at: 2026-03-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1607962/000117891326000875/0001178913-26-000875-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1607962/000117891326000875/zk2634572.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001178913-26-000875
- JSON: https://secwatch.observer/filing/0001178913-26-000875.json
- Plain text: https://secwatch.observer/filing/0001178913-26-000875.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.